Nektar Therapeutics
NKTR
#6169
Rank
S$1.16 B
Marketcap
S$57.13
Share price
2.25%
Change (1 day)
212.22%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): S-$10.39

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is S-$10.24. In 2024 the company made an earnings per share (EPS) of S-$11.38 an increase over its 2023 EPS that were of S-$28.14.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$10.39-8.78%
2024S-$11.38-59.54%
2023S-$28.14-25.89%
2022S-$37.97-31.12%
2021S-$55.1214.86%
2020S-$47.99-1.19%
2019S-$48.57-163.96%
2018S$75.94-725.4%
2017S-$12.14-42.73%
2016S-$21.2083.33%
2015S-$11.5639.53%
2014S-$8.29-69.29%
2013S-$26.98-6.67%
2012S-$28.91

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
S$16.74-263.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$2.21-121.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$9.76-195.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Richardson Electronics
RELL
S$0.01285-100.13%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$3.90-138.08%๐Ÿ‡ฌ๐Ÿ‡ง UK
Baxter
BAX
S-$0.85-91.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
S$2.66-125.97%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Johnson & Johnson
JNJ
S$13.41-230.98%๐Ÿ‡บ๐Ÿ‡ธ USA